Management of pregnancies with RhD alloimmunisation

British Medical Journal

Volumn 330, Issue 7502, 2005, Pages 1255-1258

  Kumar, Sailesh ^a   Regan, Fiona ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; MATERNAL ANTIBODY; RHESUS D ANTIGEN; STEROID;

ALLOIMMUNIZATION; AMNIOCENTESIS; ANEMIA; ASCITES; BLOOD SAMPLING; CLINICAL TRIAL; DELIVERY; DOPPLER ECHOGRAPHY; EDEMA; FETUS; FETUS ANEMIA; FETUS HYDROPS; FETUS MONITORING; GENOTYPE; HEMOLYSIS; HUMAN; IMMUNOPROPHYLAXIS; INCIDENCE; INTRAUTERINE BLOOD TRANSFUSION; MEDLINE; META ANALYSIS; NERVE CELL DIFFERENTIATION; NEWBORN; NEWBORN ANEMIA; NEWBORN HEMOLYTIC DISEASE; NON INVASIVE MEASUREMENT; OUTCOMES RESEARCH; PATHOPHYSIOLOGY; PATIENT MONITORING; PATIENT SELECTION; PERICARDIAL EFFUSION; PLEURA EFFUSION; PREGNANCY; PRIORITY JOURNAL; REVIEW; RHESUS ALLOIMMUNIZATION; SURVIVAL RATE; SYSTEMATIC REVIEW;

EID: 20344375487     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.330.7502.1255     Document Type: Review

References (29)

1. Bowman JM. The prevention of Rh immunization. Transfus Med Rev 1988;2:129-50.
2. Landsteiner K, Weiner AS. An agglutinable factor in human blood recognised by immune sera for Rhesus blood. Proc Soc Exp Biol Med 1940;43:223.
3. Bowman JM, Pollock JM, Penston LE. Fetomaternal transplacental hemorrhage during pregnancy and after delivery. Vox Sang 1986;51:117-21.
4. Royal College of Obstetricians and Gynaecologists. Green top guidelines. Anti-D immunoglobulin for Rh prophylaxis. London: RCOG, 2002.
5. National Institute for Clinical Excellence. Guidelines. Pregnancy- routine anti-D prophylaxis for rhesus negative women (No. 41). London: NICE, 2002.
6. Nicolaides KH, Rodeck CH. Maternal serum anti-D antibody concentration and assessment of rhesus isoimmunisation. BMJ 1992;304:1155-6.
7. Lo YM, Bowell PJ, Selinger M, Mackenzie IZ, Chamberlain P, Gillmer MD, et al. Prenatal determination of fetal rhesus D status by DNA amplification of peripheral blood of rhesus-negative mothers. Ann N Y Acad Sci 1994;731;229-36.
8. Finning KM, Martin PG, Soothill PW, Avent ND, et al. Prediction of fetal D status from maternal plasma: introduction of a new noninvasive fetal RHD genotyping service. Transfusion 2002;42:1079-85.
9. Mari G, Deter RL, Carpenter RL, Rahman F, Zimmerman R, Moise KJ Jr, et al. Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses. N Engl J Med 2000;342:9-14.
10. Bullock R, Martin WL, Coomarasamy A, Kilby MD. Prediction of fetal anemia in pregnancies with red-cell alloimmunization: comparison of middle cerebral artery peak systolic velocity and amniotic fluid OD450. Ultrasound Obstet Gynecol 2005;25:331-4.
11. Liley AW. Liquor amnil analysis in the management of the pregnancy complicated by resus sensitizauon. Am J Obstet Gynecol 1961;82:1359-70.
12. Maxwell DJ, Johnson P, Hurley P, Neales K, Allan L, Knott P. Fetal blood sampling and pregnancy loss in relation to indication. Br J Obstet Gynaecol 1991,98(9):892-7.
13. Klumper FJ, van Kamp IL, Vandenbussche FP, Meerman RH, Oepkes D, Scherjon SA, et al. Benefits and risks of fetal red-cell transfusion after 32 weeks gestation. Eur J Obstet Gynecol Reprod Biol, 2000;92:91-6.
14. Pattison NS, Roberts AB, Mantell N. Intrauterine fetal transfusion, 1963-90. Ultrasound Obstet Gynecot 1992;2:329-32.
15. Grab D, Paulus WE, Bommer A, Buck G, Terinde R, Treatment of fetal erythroblastosis by intravascular transfusions: outcome at 6 years. Obstet Gynecol 1999;93:165-8.
16. van Kamp IL, Klumper FJ, Bakkum RS, Oepkes D, Meerman RH, Scherjon SA, et al. The severity of immune fetal hydrops is predictive of fetal outcome after intrauterine treatment. Am J Obstet Gynecol 2001;185:668-73.
17. De Groot CJ, Oepkes D, Egberts J, Kanhai HH. Evidence of endothelium involvement in the pathophysiology of hydrops fetalis? Early Hum Dev 2000;57(3):205-9.
18. Berger HM, Lindeman JH, van Zoeren-Grobben D, Houdkamp E, Schrijver J, Kanhai HH. Iron overload, free radical damage, and rhesus haemolytic disease. Lancet 1990;335:933-6.
19. Schumacher B, Moise KJ Jr. Petal transfusion for red blood cell alloimmunization in pregnancy. Obstet Gynecol 1996;88:137-50.
20. Peterec SM. Management of neonatal Rh disease. Clin Perinatal 1995;22:561-92.
21. Millard DD, Gidding SS, Socol ML, MacGregor SN, Dooley SL, Ney JA, et al. Effects of intravascular, intrauterine transfusion on prenatal and postnatal hemolysis and erythropoiesis in severe fetal isoimmunization. J Pediatr 1990;117:447-54.
22. Scaradavou A, Inglis S, Peterson P, Dunne J, Chervenak F, Bussel J. Suppression of erythropoiesis by intrauterine transfusions in hemolytic disease of the newborn: use of erythropoietin to treat the late anemia. J Pediatr 1993;123:279-84.
23. Saade GR, Moise KJ, Belfort MA, Hesketh DE, Carpenter RJ, Fetal and neonatal hematologic parameters in red cell alloimmunization: predicting the need for late neonatal transfusions. Fetal Diagn Ther 1993;8:161-4.
24. Ovali F, Samanci N, Dagoglu T. Management of late anemia in, Rhesus hemolytic disease: use of recombinant human erythropoietin (a pilot study). Pediatr Res 1996;39:831-4.
25. Hudon L, Moise KJ Jr, Hegemier SE, Hill RM, Moise AA, Smith EO, et al. Long-term neurodevelopmental outcome after intrauterine transfusion for the treatment of fetal hemolytic disease. Am J Obstet Gynecol 1998;179:858-63.
26. Cannon M, Jones PB, Murray RM. Obstetric complications and schizophrenia: historical and meta-analytic review. Am J Psychiatry 2002;159:1080-92.
27. Voto LS, Mathet ER, Zapaterio JL, Orti J, Lede RL, Margulies M. High-dose gammaglobulin (IVIG) followed by intrauterine transfusions (IUTs): a new alternative for the treatment of severe fetal hemolytic disease. J Perinat Med 1997;25:85-8.
28. Troncek DF, Procter JL, Moses L, Bolan C, Pomper GJ, Conroy-Cantilena C, et al. Intravenous Rh immune globulin prevents alloimmunization in D-granulocyte recipients but obscures the detection of an alloanti-K. Immunohematology 2001;17:37-41.
29. Whitecar Pw, Farb R, Subramanyam L, Dorman K, Balu RB, Moise KJ Jr, et al. Paternal leukocyte alloimmunization as a treatment for hemolytic disease of the newborn in a rabbit model. Am J Obstet Gynecol 2002;187:977-80.